Cantillon Capital Management Llc Decreased Agilent Technologies Inc (NYSE:A) Stake By $21.28 Million

February 14, 2018 - By Kurt Siggers

Investors sentiment increased to 1.4 in 2017 Q3. Its up 0.18, from 1.22 in 2017Q2. It improved, as 26 investors sold A shares while 166 reduced holdings. 74 funds opened positions while 194 raised stakes. 267.56 million shares or 0.84% less from 269.83 million shares in 2017Q2 were reported. Skylands Capital Limited Liability Corp holds 6,550 shares or 0.06% of its portfolio. Duncker Streett And reported 1,400 shares. Fruth Investment reported 50,101 shares. San Francisco Sentry Inv Grp Incorporated (Ca) has 16,207 shares. Canada Pension Plan Board reported 969,719 shares or 0.13% of all its holdings. Pathstone Family Office Ltd has invested 0.02% in Agilent Technologies, Inc. (NYSE:A). Mutual Of America Capital Ltd Liability Company invested in 0.06% or 59,347 shares. Nippon Life Insur has invested 0.03% in Agilent Technologies, Inc. (NYSE:A). Hutchin Hill Limited Partnership holds 11,500 shares or 0.03% of its portfolio. Brighton Jones Lc reported 9,456 shares. 20,933 were accumulated by Retail Bank. Meiji Yasuda Life Ins owns 14,933 shares for 0.14% of their portfolio. New England Research And Mngmt invested 0.31% of its portfolio in Agilent Technologies, Inc. (NYSE:A). Rampart Investment Management Ltd Limited Liability Company has 4,363 shares. Zeke Capital Advsrs Limited Liability Corporation holds 0.05% of its portfolio in Agilent Technologies, Inc. (NYSE:A) for 5,899 shares.

Since August 16, 2017, it had 0 insider buys, and 10 insider sales for $14.15 million activity. Shares for $764,761 were sold by Doak Mark. Kaltenbach Patrick sold 5,000 shares worth $316,300. $806,434 worth of Agilent Technologies, Inc. (NYSE:A) was sold by Grau Dominique. On Thursday, January 18 the insider McMullen Michael R. sold $1.58 million. KOH BOON HWEE also sold $286,335 worth of Agilent Technologies, Inc. (NYSE:A) shares.

William Von Mueffling decreased its stake in Agilent Technologies Inc (NYSE:A) by 6.62% based on its latest 2017Q4 regulatory filing with the SEC. Cantillon Capital Management Llc sold 322,360 shares as the company’s stock rose 8.72% with the market. The hedge fund run by William Von Mueffling held 4.55 million shares of the capital goods company at the end of 2017Q4, valued at $304.60 million, down from 4.87M at the end of the previous reported quarter. Cantillon Capital Management Llc who had been investing in Agilent Technologies Inc for a number of months, seems to be less bullish one the $22.05 billion market cap company. The stock decreased 0.13% or $0.09 during the last trading session, reaching $68.34. About 1.83 million shares traded. Agilent Technologies, Inc. (NYSE:A) has risen 25.96% since February 14, 2017 and is uptrending. It has outperformed by 9.26% the S&P500.

William von Mueffling graduated with an MBA from Columbia in 1995 and went to work immediately in Germany and France for Deutsche Bank. He would later join Lazard Asset Management where he would become the managing director for hedge funds. His rise at Lazard saw him compared to rock stars. Boasting annual average returns of over 30% for 1998 to 2003, Mueffling gained such laudable numbers mostly by the shorting of technology stocks. He would go on to found Cantillon Capital in 2003, and he remains the present and CEO of that firm today. Cantillon Capital Management Llc is a New York-based hedge fund that was founded by William Von Mueffling. It had more than $12.49 billion assets under management in March, 2014. This fund invests only a small percentage of its assets in equities and options. Taken from Cantillon Capital Management latest Adv, the fund reported to have 21 full and part-time employees. Among which 21 performing investment advisory and research functions. The hedge fund had between 11-25 clients.

Agilent Technologies, Inc. (NYSE:A) Ratings Coverage

Among 14 analysts covering Agilent Technologies (NYSE:A), 10 have Buy rating, 0 Sell and 4 Hold. Therefore 71% are positive. Agilent Technologies has $88 highest and $5 lowest target. $68’s average target is -0.50% below currents $68.34 stock price. Agilent Technologies had 53 analyst reports since August 14, 2015 according to SRatingsIntel. Robert W. Baird maintained it with “Buy” rating and $72.0 target in Monday, November 20 report. Deutsche Bank initiated Agilent Technologies, Inc. (NYSE:A) on Wednesday, January 18 with “Buy” rating. The stock has “Buy” rating by Evercore on Thursday, August 18. Cowen & Co maintained the stock with “Hold” rating in Tuesday, August 15 report. Barclays Capital upgraded Agilent Technologies, Inc. (NYSE:A) on Wednesday, January 4 to “Overweight” rating. The stock of Agilent Technologies, Inc. (NYSE:A) earned “Outperform” rating by Cowen & Co on Thursday, May 26. Goldman Sachs maintained the shares of A in report on Thursday, August 18 with “Buy” rating. On Friday, October 6 the stock rating was maintained by Morgan Stanley with “Overweight”. The rating was maintained by Robert W. Baird with “Outperform” on Monday, September 18. The company was maintained on Thursday, August 18 by BTIG Research.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company has market cap of $22.05 billion. The Company’s Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. It has a 32.54 P/E ratio. The companyÂ’s Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients.

More recent Agilent Technologies, Inc. (NYSE:A) news were published by: which released: “Is a Surprise Coming for Agilent Technologies (A) This Earnings Season …” on February 13, 2018. Also published the news titled: “Agilent Technologies (A) Appoints Dow R. Wilson to Board” on January 18, 2018.‘s news article titled: “Is a Surprise Coming for Agilent Technologies (A) This Earnings Season?” with publication date: February 13, 2018 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.